Today, were looking at Dow Jones Industrial Average component Pfizer (NYSE: PFE
). For many years, it was focused almost exclusively on pharmaceuticals, but
like many of the big pharma companies, it determined it was necessary to buy
other companies to buttress its pipeline. Warner-Lambert was Pfizer's biggest
target, but it has swallowed other companies as well, including Immunex. Now
Pfizers Biopharmaceuticals segment provides big drugs like Lipitor, Enbrel,
Lyrica, Prevnar, Celebrex, Viagra, Effexor, Ariscept and Norvasc, among many
others. Its Diversified Business segment includes animal health and consumer
health care categories that offer pain management, respiratory and personal care
products, as well as dietary supplements and nutritional products. The key
driving factors regarding Pfizer are research and development, the economy and
competition. R&D is the real reason behind those mega-purchases over the past
decade, and as you can see, the companys list of well-known blockbuster drugs is
enormous. As with competitor
No comments:
Post a Comment